Aspen Healthcare, a division of Aspen Pharmacare Holdings Limited, the largest listed pharmaceutical company in Africa, was founded in 2009 to bring the Aspen Group’s expanding portfolio of pharmaceutical and consumer healthcare products to the Middle East, North Africa and Turkey (MENAT). Headquartered in Dubai, the commercial operation was established in 2010 when the first partnerships were sealed to leverage the global acquisitions in the region. The MENAT team follows the Aspen Group’s vision to focus on therapeutic portfolios that include anaesthetics and thrombosis. Key products include Diprivan, Emla, Solpadeine and Arixtra. From 3 employees in 2009 to 210 today, Aspen Healthcare rapidly grew establishing itself as a key healthcare player in the MENAT region. Since 2009 our Dubai headquarters has been home to the commercial team as well as the Shared Services Hub, which handles financial and IT related support for Aspen entities in Europe, MENAT and Canada. Aspen Healthcare strives to offer patients and stakeholders the best possible experience throughout the region and beyond.